Publications by authors named "Zachary Hubshman"
Article Synopsis
- Alcohol Use Disorder (AUD) significantly impacts global mortality, and new medications like GLP-1 and GLP-1/GIP agonists show promise in reducing alcohol consumption, particularly in individuals with obesity.
- The study included a social media analysis of posts related to these medications on Reddit, revealing themes around medication effects, diabetes, and notable mentions of craving reduction and decreased desire to drink in 71% of alcohol-related posts.
- A remote study with 153 participants showed that those taking GLP-1 or GLP-1/GIP agonists reported significantly lower alcohol consumption, binge drinking, and related negative effects compared to a control group, indicating the potential for these medications to help treat AUD in obese individuals.
